| Michelle Tippens, | |
|
4900 Ivey Rd Nw Ste 1720, Acworth, GA 30101-4101 | |
| (770) 917-5737 | |
| Not Available |
| Full Name | Michelle Tippens |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4900 Ivey Rd Nw Ste 1720, Acworth, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245913680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | PCET003892 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Tippens, 1858 Hawks Ridge Ct, Lawrenceville, GA 30043-6642 Ph: (770) 601-3811 | Michelle Tippens, 4900 Ivey Rd Nw Ste 1720, Acworth, GA 30101-4101 Ph: (770) 917-5737 |
News Archive
Roll Call reports that the Administration's alliances with major health organizations may not be as strong as previously thought. "An analysis of these groups' positions suggests few are completely on board and several may oppose the president in the end.
A new type of CT scan initially costs slightly less than the traditional stress test to diagnose blocked coronary arteries in patients with chest pain, but its lower cost did not translate into medical care savings over time, according to an analysis by Duke Medicine researchers.
The University of Bristol is already world-famous for its biomedical research, but following a £2.3 million investment in newly refurbished labs, it will be able to advance techniques that look in even greater detail at what's going on in our bodies.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
The U.S. Food and Drug Administration has approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.
› Verified 1 days ago
Mrs. Caren Malin Doleys, M.ED, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1120 Regiment Dr Nw, Acworth, GA 30101 Phone: 678-557-9581 Fax: 678-574-6695 | |
Gift Of Gab Speech Therapy Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4811 Village Sq Nw, Acworth, GA 30102 Phone: 404-665-7804 | |
Shaniqua Evans, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4900 Ivey Rd Nw Ste 1720, Acworth, GA 30101 Phone: 770-917-5737 | |
Karen Casadaban, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4957 Day Lily Way, Acworth, GA 30102 Phone: 770-592-4313 Fax: 770-592-4314 | |
Mrs. Lindsey Caroline Hamby, M.ED. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4900 Ivey Rd Nw Ste 1720, Acworth, GA 30101 Phone: 770-917-5737 | |
Tammy Tomlinson Southers, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4900 Ivey Rd Nw Ste 1720, Acworth, GA 30101 Phone: 770-917-5737 | |
Megan Elizabeth Lane, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4900 Ivey Rd Nw Ste 1720, Acworth, GA 30101 Phone: 770-917-5737 |